{"id":111817,"title":"Genedrive PLC (AIM:GDR) Initial overseas orders of MT-RNR1 ID kit","publisher":"Share Talk","author":"sharetalk","published":"2023-12-20T08:19:26+00:00","modified":"2023-12-20T08:19:26+00:00","canonical_url":"https://www.share-talk.com/genedrive-plc-aimgdr-initial-overseas-orders-of-mt-rnr1-id-kit/","markdown_url":"https://www.share-talk.com/genedrive-plc-aimgdr-initial-overseas-orders-of-mt-rnr1-id-kit.md","json_url":"https://www.share-talk.com/genedrive-plc-aimgdr-initial-overseas-orders-of-mt-rnr1-id-kit.json","category":"Health","categories":["Health","Healthcare","Pharmaceutical"],"tags":["Antibiotic","biological","chemistry","coronavirus","COVID-19","COVID19","David Budd","diagnostics","GDR","Genedrive","Genedrive Kit","Genedrive PLC","hospital","infectious diseases","lab testing","Manchester","Matthew Fowler","molecular","SARS-COV-2","Share Talk"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/12/Genedrive.jpg?fit=1200%2C800&quality=89&ssl=1","format":"news","language":"en-GB","content":"**Initial overseas orders of the Genedrive® MT-RNR1 ID Kit**\n\n**genedrive plc (AIM: GDR),** the point of care Pharmacogenetic testing company, announces that initial orders of the Genedrive® MT-RNR1 products have been received from France, Austria, Greece, Saudi Arabia, Turkey and the Netherlands. This follows the Company recently confirming that commercial distribution agreements for the genedrive test for antibiotic induced hearing loss (“AIHL”) in a number of countries had been signed.\n\nThe initial orders will support genedrive’s international distribution partners in promotion and in-country evaluation activities in their respective countries, to provide more extensive access to this life-changing test.\n\n**James Cheek, Chief Executive Officer of genedrive plc, said:** “We are delighted to see the first orders come in from those countries we have signed distribution agreements with. We look forward to the continued expansion of our international sales throughout 2024 as we drive forward with our sales and marketing strategies and deliver value to our shareholders.”\n\nFor further details, please contact:\n\n|   |   |\n| --- | --- |\n| genedrive plc | +44 (0)161 989 0245 |\n| James Cheek: CEO / Russ Shaw: CFO |  |"}